­
­
­
­

Inventi Impact - Planta Activa

Patent Watch

  • Alkaloid compounds and their use as anti-malarial drugs

    Anti-malarial alkyloid compounds have the formula: ##STR00001## wherein R.sub.1-R.sub.11 have various disclosed values or their pharmaceutically acceptable salts, and pharmaceutical compositions containing the same.

  • Coumarin derivative having antitumor activity

    The present invention provides a compound represented by general formula (1) below or a pharmaceutically acceptable salt thereof: ##STR00001## wherein: X is selected from heteroaryl etc., Y.sup.1 and Y.sup.2 are selected from --N.dbd. etc., Y.sup.3 and Y.sup.4 are selected from --CH.dbd. etc., A is selected from sulfamide etc., R.sup.1 is selected from hydrogen etc., and R.sup.2 is selected from C.sub.1-6 alkyl etc. The compound or salt has sufficiently high antitumor activity, and is useful in the treatment of cell proliferative disorders, particularly cancers. The present invention also provides a pharmaceutical composition containing the compound or salt as an active ingredient.

  • Purifications of pomegranate ellagitannins and their uses thereof

    Compositions of purified and biologically active ellagitannins are provided by separation from pomegranate husk using a method of extraction and purification using a solid polymeric adsorbent and the uses of the said compounds.

  • 15-OXA-steroid compounds

    The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the invention include methyl-2,3,4-trihydroxy-1-O-(7,17-dioxoandrost-5 -ene-3.beta.-yl)-.beta.-D-glucopyranosiduronate, 16.alpha.,3.alpha.-dihydroxy-5.alpha.-androstan-17-one or 3,7,16,17 -tetrahydroxyandrost-5-ene, 3,7,16,17-tetrahydroxyandrost-4-ene, 3,7,16,17 -tetrahydroxyandrost-1-ene or 3,7,16,17-tetrahydroxyandrostane that can be used in the treatment method.

  • Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals

    The disclosure provides a method for isolating the bioactive component of the water-soluble extract of Uncaria tomentosa known as C-MED-100.RTM., comprising (i) precipitating the spray drying carrier from C-MED-100.RTM.; (ii) using the resulting C-MED-100.RTM. to obtain a spotting mixture for thin layer chromatography (TLC); (iii) spotting the C-MED-100.RTM. spotting mixture on pre-run TLC plates and eluting the plates to obtain the fluorescing band with R.sub.f=0.2-0.3; (iv) scraping off the R.sub.f=0.2-0.3 band, eluting it in ammonia and freeze drying the eluted band to form a powder; and (v) extracting the powder with methanol to remove solubilized silica gel, concentrating the methanol solution and crystallizing the concentrated solution to obtain the bioactive component. The isolated bioactive component in vitro is a quinic acid analog, preferably quinic acid lactone. By contrast, the disclosure further shows the isolated bioactive component in vivo is quinic acid, whether as free acid or as a quinic acid salt, including quinic acid ammonium salt. The disclosure then provides for a pharmaceutical composition comprising a pharmaceutically effective amount of the bioactive component and a nontoxic inert carrier or diluent. The pharmaceutical composition and bioactive component may be used to enhance immune competency, treat disorders associated with the immune system, inhibit the inflammatory response, treat disorders associated with the inflammatory response, enhance the anti-tumor response, and treat disorders associated with the response to tumor formation and growth, all in mammals.

  • Lutein extraction from ozone-treated plant sources

    The use of ozonation has been discovered to increase the lutein extraction from aflatoxin-free corn and for some batches of alfalfa. In addition, the ozonation will substantially decrease any aflatoxin in the plant source. The structure of lutein as indicated by HPLC elution profile and the function of lutein using an antimutagenic activity was shown not to be affected by the ozonation.

  • Method of Treating Neurological Conditions with Cardiac Glycoside

    A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside to a subject. The cardiac glycoside can be present in a dosage form.

  • MANIPULATION OF AMMONIUM TRANSPORTERS (AMTS) TO IMPROVE NITROGEN USE EFFICIENCY IN HIGHER PLANTS

    The present invention provides polynucleotides and related polypeptides of the protein AMT. The invention provides genomic sequence for the AMT gene. AMT is responsible for controlling nitrogen utilization efficiency in plants.

  • Method of Enhancing Biological Activity of Plant Extracts

    The present invention relates to a method of modulating a selected biological activity of a naturally occurring material having one or more biological activities in an extract of the naturally occurring material, the method comprising incubating the extract in a medium in the presence of an aerobically metabolizing microorganism, under suitable aerobic conditions, for a period of time sufficient to modulate the selected activity with respect to baseline activity of the unincubated extract. The invention also relates to the bioconverted material so prepared, and the use of same in cosmetic or pharmaceutical compositions.

  • RICE PROMOTERS FOR REGULATION OF PLANT EXPRESSION

    The present invention provides promoters from plants capable of driving gene expression in plant cells. The promoters vary in strength and in tissue specificity, and can be used to facilitate the development of transgenic plants in which tissue preferred expression, constitutive expression, and the strength of transgene expression is either more or less critical.

  • XANTHOHUMOL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES OR DISORDERS

    The present invention features therapeutic and prophylactic compositions comprising xanthohumol and/or xanthohumol/cyclodextrin complexes and methods of using such compositions for treating a skin condition, disease, or disorder.

  • Anti-inflammatory cranberry flavonol extract preparations

    The present invention is directed to extracts of cranberries (Vaccinium macrocarpon) comprising either mixed flavonols that are substantially free of anthocyanins and proanthocyanidins or a purified cranberry flavonol compound, including myricetin-3-.beta.-xylopyranoside, quercetin-3-.beta.-glucoside, quercetin-3-.alpha.-arabinopyranoside, 3'-methoxyquercetin-3-.alpha.-xylopyranoside, quercetin-3-O-(6''-p-coumaroyl)-.beta.-galactoside, and quercetin-3-O-(6''-benzoyl)-.beta.-galactoside. The present invention also embodies the use of those extracts, as well as extracts comprising the cranberry flavonol compound quercetin-3-.alpha.-arabinofuranoside, for the treatment of inflammatory disorders. Pharmaceutical, food, dietary supplement, and cosmetic compositions utilizing the extracts or compounds of the present invention are also recited.

  • MATERIALS AND METHODS FOR MODULATING SEED SIZE, SEED NUMBER, AND SEED SUGAR CONTENT IN PLANTS

    The subject invention concerns materials and methods for modulating seed size in plants. In one embodiment, seed size is decreased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (Sdh) gene or the gene product thereof. In another embodiment, seed size is increased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof. The subject invention also concerns materials and methods for modulating seed number or sugar content in plants. In one embodiment, seed number or sugar content is increased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (Sdh) gene or the gene product thereof. In another embodiment, seed number or sugar content is decreased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof.

  • ENGINEERING PLANT RESISTANCE TO DISEASES CAUSED BY PATHOGENS

    Methods for identifying one or more amino acid substitutions in an oxalate oxidase (OXOX) variant polypeptide that confer maintained or increased OXOX activity are described herein. Methods and compositions for increasing a plant's resistance to a pathogen using the modified OXOX variant polypeptides are provided. Transformed plants, plant cell, tissues, seed, and expression vectors are also provided.

  • Method of Treating Neurological Conditions with Cardiac Glycoside

    A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside to a subject. The cardiac glycoside can be present in a dosage form.

  • CONTROL OF SO2 METABOLISM IN PLANTS AND ITS APPLICATIONS

    SO-transgenic plants overexpressing or lacking SO activity, having modified tolerance or susceptibility to toxicity of sulfite-producing substances, methods for their production and the use thereof for bioremediation of pollutants, as sentinel plants, for enhancing post-harvest quality of plants, plant tissues and plant products and for therapeutic applications.

  • CONTROL SYSTEM FOR PHOTOVOLTAIC POWER PLANT

    A control system for a photovoltaic ("PV") power plant that includes a plant-level control system for implementing plant-level control functions at power generation sites of the plant, a supervisory system for supervisory control and data acquisition of the plant, and a communications network connecting the plant-level control system, the supervisory system, and plant devices is described. Methods of controlling a PV plant using the plant-level control system and the supervisory system and methods of regulating power characteristics in power generation sites are also described.

  • Standardization of Botanical Products Utilizing Biological Activity as a Marker

    The present invention relates generally to herbal materials and methods for making such materials in medicinally useful and pharmaceutically acceptable forms. Particularly, the present invention relates generally to Hydrstatis canadensis (goldenseal) materials and methods for making such materials in medicinally useful and pharmaceutically acceptable forms. More particularly, the present invention relates a process which allows the standardization of the product to specified levels of bioactivity in both hydro-alcoholic tinctures and solid extracts in the processing of goldenseal materials to produce extracts which qualify as pharmaceutical grade compositions which are suitable for use in clinical or veterinary settings to treat and/or ameliorate diseases, disorders or conditions.

  • HERBICIDE-RESISTANT SUNFLOWER PLANTS WITH MULTIPLE HERBICIDE RESISTANT ALLELES OF AHASL1 AND METHODS OF USE

    Herbicide resistant sunflower plants comprising two different herbicide-resistant alleles of the sunflower acetohydroxyacid synthase large subunit 1 (AHASL1) gene are described. Methods for making these sunflower plants and methods for controlling weeds or other undesired vegetation growing in the vicinity of these sunflower plants are disclosed. Such methods involve the use of acetohydroxyacid synthase-inhibiting herbicides. Methods for controlling parasitic weeds growing on sunflower plants are also described. Additionally provided are methods for determining the genotype of sunflower plants for AHASL1 gene.

  • Plants with Reduced Activity of a Starch Phosphorylating Enzyme

    The present invention relates to plant cells and plants, which are genetically modified, wherein the genetic modification leads to the reduction of the activity of a starch phosphorylating OK1 protein in comparison with corresponding wild type plant cells or wild type plants that have not been genetically modified. Furthermore, the present invention relates to means and methods for the manufacture of such plant cells and plants. Plant cells and plants of this type synthesise a modified starch. The present invention therefore also relates to the starch synthesised by the plant cells and plants according to the invention, methods for the manufacture of this starch, and the manufacture of starch derivatives of this modified starch, as well as flours containing starches according to the invention. Furthermore, the present invention relates to nucleic acid molecules, which are suitable for manufacturing plants according to the invention.

  • Xanthomonas Campestris Pv. Campestris Resistant Brassica Plant and Preparation Thereof

    The present invention relates to a Xanthomonas campestris pv. campestris (Xcc) resistant Brassica plant, and seeds, fruits and or plant parts thereof, and to methods for preparation thereof. Specifically, the present invention relates to a Xcc resistant Brassica oleracea plant, and seeds, fruits and/or plant parts thereof, and methods for preparation thereof. Further, the present invention relates to Quantitative Trait Loci (QTL's) providing the present Xcc resistance and molecular markers, specifically Random Amplified Microsatellite Polymorphism (RAMP) markers, for identifying the present QTL's.

  • COMPOSITION COMPRISING BAMBOO EXTRACT AND THE COMPOUNDS ISOLATED THEREFROM SHOWING ACTIVITY FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY AND BLOOD CIRCULATION DISEASE

    The present invention relates to a composition comprising a bamboo plant extract for the prevention and treatment of inflammatory or blood circulation disease. The extracts from bamboo plant have potent anti-inflammatory activity by inhibiting NO production and circulation-improving activity by inhibiting elastase activity and, healing the wound of vascular endothelial cell, activating u-PA expression and inhibiting PAI-1 expression, lowering cholesterol deposit and inhibiting neointima formation, therefore it can be used as the therapeutics or health care food for treating and preventing inflammatory or blood circulation diseases.

  • Composition comprising longan arillus extract or combined extract comprising the same for treating neurodegenerative disease

    This disclosure relates to a composition for prevention or treatment of neurodegenerative disease comprising longan arillus extract, or combined extract comprising longan arillus. The composition exhibits remarkably excellent prevention or treatment effect of neurodegenerative disease by containing longan arillus extract or combined extract comprising longan arillus, and particularly, it may effectively prevent or treat neurodegenerative disease by significantly protecting dopaminergic neurons from neurotoxicity due to MPTP selectively acting on dopaminergic nervous system and neurotoxicity due to aggregation of alpha-synuclein proteins.

  • METHOD FOR SELECTION OF NOVEL ANTI-CANCER HERBS USING CHEMINFORMATIC TOOLS

    The various embodiments herein provide a new method of selecting novel anti-cancer herbs using cheminformatics tools. The method involves collecting the herbs having synergistic activity with anti-cancer compounds and categorizing the herbs as synergistic plants (SP). The bioactive compounds are selected from the SP and categorized into synergistic compounds collection (SCC). A similarity search is performed using the selected bioactive compounds through available databases to select similar compounds that are categorized as similar synergistic compounds (SSC). A herbal source for the SSC is searched and categorized as similar herbal synergistic compounds (SHSC). The novelty of the SHSC in cancer treatment is confirmed. The novel herbs are categorized as novel candidate herbs (NCH). The synergistic activity of the resulted herbs (NCH) is confirmed by performing in vitro bioassay.

  • Apparatus and method for determining the health effects associated with various products

    There is provided an apparatus and method for determining health effect of a selected product, or products(s) providing a selected health effect. The apparatus comprises a database of products and associated health effects; an input for a user to input the selected product or selected health effect; a processor for determining health effect of the selected product from the database and/or for determining product(s) from the database providing the selected health effect; and an output for outputting information to the user. The method comprises the steps of providing a database of products and associated health effects; inputting the selected product or selected health effect into a user input; determining health effect of the selected product from the database, or product(s) from the database providing the selected health effect; and outputting information to the user.

  • USE OF THE COMBINATION OF PHY906 AND A TYROSINE KINASE INHIBITOR AS A CANCER TREATMENT REGIMEN

    This invention provides herbal compositions useful for increasing the therapeutic index of chemotherapeutic compounds. This invention also provides methods useful for improving the quality of life of an individual undergoing chemotherapy. Furthermore, this invention improves the treatment of cancer by administering the herbal composition PHY906 in combination with one or more chemotherapeutic compounds to a mammal undergoing such chemotherapy.

  • BURDOCK FRUIT EXTRACT CONTAINING ARCTIGENIN AT HIGH CONTENT AND PROCESS FOR PRODUCING SAME

    PROBLEM TO BE SOLVED A burdock fruit extract containing arctigenin at high content and its production method are provided, and both of which are used for treatment of pancreatic cancer. SOLUTION The burdock fruit extract containing arctigenin at high content by enzymatically converted arctiin into arctigenin with beta-glucosidase, which is an enzyme occurring endogenously in a burdock fruit, and adding ethanol, extracting, concentrating and then freeze-drying or spray drying.

  • USE OF EXTRACTS OF PEZIZACEAE IN THE PREVENTION AND/OR TREATMENT OF SENILE CATARACTS

    The invention provides methods for treating and/or preventing the recurrence of a senile cataract, and/or for inhibiting the development of a senile cataract and/or an incipient senile cataract, in a human or animal subject. The invention further provides nutraceutical compositions suited for the same, derived from an extract of truffles (Pezizaceae). The compositions comprise the extract in a therapeutically sufficient amount for the treatment and/or prophylaxis of a senile cataract in a human and/or animal subject.

  • COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONS

    Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In particular extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.

  • ANTI-BIOFILM COMPOSITIONS AND METHODS FOR USING

    The present invention provides polyphenolic compositions derived from a plant that inhibit the formation of a biofilm. Also provided are combinations that comprise at least one phenolic phytochemical and at least one antimicrobial agent that inhibit the growth of an established biofilm. Further, the present invention provides methods for inhibiting the formation and growth of biofilms.

  • PLANT-SPECIFIC GENETIC ELEMENTS AND TRANSFER CASSETTES FOR PLANT TRANSFORMATION

    The present invention provides nucleic acid molecules and sequences, particularly those identified and obtained from plants, that are useful for transferring and integrating one polynucleotide into another via plant transformation techniques.

  • PLANT-SPECIFIC GENETIC ELEMENTS AND TRANSFER CASSETTES FOR PLANT TRANSFORMATION

    The present invention provides nucleic acid molecules and sequences, particularly those identified and obtained from plants, that are useful for transferring and integrating one polynucleotide into another via plant transformation techniques.

  • Herbal Drug Composition for Cartilage Protection

    The present invention relates to a herbal drug composition for cartilage protection comprising plant extracts of Clematis Radix, Trichosanthis Radix, and Prunellae Spica and an optimal content of rosmarinic acid to: (i) alleviate pains; (ii) inhibit the acute/chronic inflammation, platelet/whole blood aggregation, immunocyte (B-lymphcyte and T-lymphcyte) proliferation, inflammation-inducing enzyme activities, and enzyme activities associated with degradation of joint tissue; (iii) scavenge activity of toxic active oxygen radicals; and (iv) further provide excellent cartilage protection activity to be effectively used as an anti-inflammatory agent with analgesic effects, blood circulation enhancer, arthritis therapeutic agent and cartilage protective.

  • OPIOID RECEPTORS STIMULATING COMPOUNDS (THYMOQUINONE, NIGELLA SATIVA) AND FOOD ALLERGY

    The present invention relates generally to the fields of food allergy and nutrition. It was found that the stimulation of opioid receptors could be used to treat or prevent food allergy. One embodiment of the present invention concerns hence the use of an opioid receptor stimulating compound like thymoquinone or plant extracts from Nigella sativa, Eupatorium ayapana, Satureja montana or Thymus for the preparation of a composition to treat or prevent food allergy.

  • SYNERGISTIC PREBIOTIC COMPOSITIONS

    The invention relates to synergistic compositions comprising prebiotic components selected from fructose polymers GF.sub.n and F.sub.m, either containing a glucose (G) end-group, or without a glucose end-group, and one or more component of a group of prebiotics consisting of modified or unmodified starch and partial hydrolysates thereof, partially hydrolysed inulin, natural oligofractoses, fructo-oligosaccharides (FOS), lactulose, galactomannan and suitable partial hydrolysates thereof, indigestible polydextrose, acemannan, various gums, indigestible dextrin and partial hydrolysates thereof, trans-galacto-oligosaccharides (GOS), xylo-oligosaccharides (XOS), beta-glucan and partial hydrolysates thereof, together if desired with phytosterol/phytostanol components and their suitable esters, and if desired other plant extracts, mineral components, vitamins and additives.

  • INSECT AND DISEASE CONTROL

    The invention provides a method for controlling pests or pathogenic organisms in an agricultural structure, the method comprising applying a pesticidal composition to surfaces susceptible to infestation or colonization by the pest or pathogenic organism, wherein the composition includes terpenoids, essential oils, plant extracts, or combinations thereof.

  • COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CORONARY HEART DISEASES

    Disclosed herein are compounds and plant extracts, and methods for preventing or treating heart diseases, including coronary heart diseases. The compounds provided herein can be formulated into pharmaceutical compositions and medicaments that are useful in the disclosed methods. Also provided are the use of the compounds and extracts in preparing pharmaceutical formulations and medicaments.

  • METHOD FOR PRODUCING AN ANTIMICROBIAL COATING ON A TECHNICAL SURFACE

    The invention relates to a method for producing a microbial substance-releasing layer on a technical surface. The inventive method comprises three steps: a) producing a solution from polyvinylacetate, a preservative agent and a solvent, b) applying the solution to the technical surface, and c) drying the solution applied to the technical surface while forming the layer. The inventive method is characterized by using benzoic acid, sorbic acid, natamycin, bacteriocines, plant extracts or mixtures thereof as the preservative agent and an ethanol/water mixture, ethyl acetate or acetone as the solvent.

  • ANTI-BIOFILM COMPOSITIONS AND METHODS FOR USING

    The present invention provides polyphenolic compositions derived from a plant that inhibit the formation of a biofilm. Also provided are combinations that comprise at least one phenolic phytochemical and at least one antimicrobial agent that inhibit the growth of an established biofilm. Further, the present invention provides methods for inhibiting the formation and growth of biofilms.

  • THERMAL TREATMENT PROCESS FOR TOBACCO MATERIALS

    A method of thermally processing a tobacco material is provided, the method including the steps of (i) mixing a tobacco material, water, and an additive selected from the group consisting of lysine, glycine, histidine, alanine, methionine, glutamic acid, aspartic acid, proline, phenylalanine, valine, arginine, di- and trivalent cations, asparaginase, saccharides, phenolic compounds, reducing agents, compounds having a free thiol group, oxidizing agents, oxidation catalysts, plant extracts, and combinations thereof, to form a moist tobacco mixture; (ii) heating the moist tobacco mixture at a temperature of at least about 60.degree. C. to form a heat-treated tobacco mixture; and (iii) incorporating the heat-treated tobacco mixture into a tobacco product. Heat-treated tobacco composition prepared according to the method are also provided, such as heat-treated smokeless tobacco composition comprising a tobacco material, water, flavorant, binder, and filler, the heat-treated smokeless tobacco composition having an acrylamide content of less than about 2000 ppb.

  • PAD FOR HERBAL MEDICINE IN WHICH RELEASE OF MEDICINAL INGREDIENT CAN BE CONTROLLED, AND MANUFACTURING METHOD THEREOF

    The present disclosure relates to a method for manufacturing a pad for herbal medicine in which the release of medicinal ingredients can be controlled, which comprises: separating two or more medicinal herbal ingredients prescribed or prepared according to pharmacological effects on the basis of the weight ratio of each medicinal ingredient to total weight of the medicinal ingredients; grinding the medicinal ingredients separated on the basis of weight ratio, wherein fine particles are ground to different sizes according to the setting of release duration; preparing herbal medicine by mixing the ground medicinal ingredients together, and then mixing the ingredients with a binding agent; and adhering the herbal medicine to a base sheet. The pad for herbal medicine manufactured according to the method allows for persistent permeation of medical ingredients through the skin with different release rate for each medicinal ingredient, and thus, the efficacy of the medicinal ingredient layer and the effect of treating disease can be maximized.

  • PAD FOR HERBAL MEDICINE IN WHICH RELEASE OF MEDICINAL INGREDIENT CAN BE CONTROLLED, AND MANUFACTURING METHOD THEREOF

    The present disclosure relates to a method for manufacturing a pad for herbal medicine in which the release of medicinal ingredients can be controlled, which comprises: separating two or more medicinal herbal ingredients prescribed or prepared according to pharmacological effects on the basis of the weight ratio of each medicinal ingredient to total weight of the medicinal ingredients; grinding the medicinal ingredients separated on the basis of weight ratio, wherein fine particles are ground to different sizes according to the setting of release duration; preparing herbal medicine by mixing the ground medicinal ingredients together, and then mixing the ingredients with a binding agent; and adhering the herbal medicine to a base sheet. The pad for herbal medicine manufactured according to the method allows for persistent permeation of medical ingredients through the skin with different release rate for each medicinal ingredient, and thus, the efficacy of the medicinal ingredient layer and the effect of treating disease can be maximized.

  • SWEETENER COMPOSITION

    A sweetener composition is provided, formed with natural plant extracts including Luo Han Guo fruit extract and sweet stevia extract, and neohesperidin dihydrochalcone (NHDC) as raw materials at a scientific and sound mixing ratio such that the disadvantage of having a strong aftertaste of water is eliminated, and the Chinese herbal medicine taste of the Luo Han Guo fruit and the bitter aftertaste of stevia sugar are effectively shielded. The sweetener composition successfully removes the Chinese herbal medicine taste of Luo Han Guo fruit and the bitter aftertaste of stevia sugar while fully exerting the herbal fresh and sweet taste of the Luo Han Guo fruit extract and the sweet stevia extract, and perfectly combines the sweet aftertaste of mogrosides, so that the sweet taste is maintained and the taste is good, and the sweetener composition of the present invention is well accepted by consumers.

  • CHINESE HERBAL MEDICINE COMPOSITION USED FOR ANTIINFLAMMATION, DETUMESCENCE AND ACESODYNE, AND PREPARATION METHOD AND USE THEREOF

    A Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, comprising first type of medicinal materials and second type of medicinal materials. The first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei. The second type of medicinal materials is one, two or three selected from the group cosisting of Zingiber Officinale, Olibanum and Myrrha. The preparation method for the Chinese herbal medicine composition comprises the following steps: adding the first type of medicinal materials and the second type of medicinal materials into a container with organic solvent, heating, filtering, and then condensing the filtrate into an extratum.

  • HERBAL COMPOSITION COMPRISING GINGER AND GOLDENROD FOR THE TREATMENT OF COLD AND FLU

    Described herein is a composition comprising a combination of ginger and goldenrod for the prevention and/or treatment of cold and/or flu infection. Also described is a method of treating or preventing a cold and/or flu infection in a subject in need thereof comprising administering to the subject an effective amount of a composition comprising a combination of ginger and goldenrod.

  • HERBAL COMPOSITION FOR REDUCING ADD/ADHD AND METHOD THEREOF

    A herbal composition comprising supercritical fluid extracts/oils of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E is effective in the treatment of symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD).

  • HERBAL COMPOSITION FOR WEIGHT MANAGEMENT

    Herbal extracts composition suitable for weight management in mammals is disclosed. The composition comprises a mixture of Garcinia extract, Green tea extract, Green coffee extract and Banaba extract. The method of reducing weight, and treating diabetes in mammals involve oral administration of the composition. The invention further relates to a method of producing and standardizing the individual extract useful for human health.

  • MEDICINAL AND HERBAL COMPOSITION AND USES THEREOF

    The subject application provides compositions and methods for treating HIV/AIDS and other diseases. The compositions contain herbs or extracts of herbs found in Kenya, and naltrexone.

  • Herbal Drug Composition for Cartilage Protection

    The present invention relates to a herbal drug composition for cartilage protection comprising plant extracts of Clematis Radix, Trichosanthis Radix, and Prunellae Spica and an optimal content of rosmarinic acid to: (i) alleviate pains; (ii) inhibit the acute/chronic inflammation, platelet/whole blood aggregation, immunocyte (B-lymphcyte and T-lymphcyte) proliferation, inflammation-inducing enzyme activities, and enzyme activities associated with degradation of joint tissue; (iii) scavenge activity of toxic active oxygen radicals; and (iv) further provide excellent cartilage protection activity to be effectively used as an anti-inflammatory agent with analgesic effects, blood circulation enhancer, arthritis therapeutic agent and cartilage protective.

  • METHOD FOR EXTRACTING A TRADITIONAL HERBAL MEDICINE COMPONENT USING A POLISHED-RICE STEAMING METHOD

    Disclosed are: a method for extracting a traditional herbal medicine component comprising a process in which a traditional oriental medicine component is steamed together with polished rice; and a composition for an external application to skin comprising an extract which has been extracted by means of the method. The component extracted by means of the extraction method reduces the cytotoxicity of the traditional oriental medicine, is recognized as being effective in alleviating skin irritation, and exhibits an outstanding skin-whitening effect.-dispensing virtual pharmacy comprising one or more computers, an electronic prescription associated with a patient, where the electronic prescription is associated with at least one drug or product prescribed for the patient; determining, by the non-dispensing virtual pharmacy, a plurality of dispensing pharmacies capable of filling the prescription; determining, by the non-dispensing virtual pharmacy, a respective total price payable to each of the plurality of dispensing pharmacies for filling the prescription for the patient; delivering, in real-time to a patient device by the non-dispensing virtual pharmacy, an identification of the plurality of dispensing pharmacies and the respective total prices; and receiving, by the non-dispensing virtual pharmacy from the patient device, a selection of one of the plurality of dispensing pharmacies.

  • PAD FOR HERBAL MEDICINE IN WHICH RELEASE OF MEDICINAL INGREDIENT CAN BE CONTROLLED, AND MANUFACTURING METHOD THEREOF

    The present disclosure relates to a method for manufacturing a pad for herbal medicine in which the release of medicinal ingredients can be controlled, which comprises: separating two or more medicinal herbal ingredients prescribed or prepared according to pharmacological effects on the basis of the weight ratio of each medicinal ingredient to total weight of the medicinal ingredients; grinding the medicinal ingredients separated on the basis of weight ratio, wherein fine particles are ground to different sizes according to the setting of release duration; preparing herbal medicine by mixing the ground medicinal ingredients together, and then mixing the ingredients with a binding agent; and adhering the herbal medicine to a base sheet. The pad for herbal medicine manufactured according to the method allows for persistent permeation of medical ingredients through the skin with different release rate for each medicinal ingredient, and thus, the efficacy of the medicinal ingredient layer and the effect of treating disease can be maximized.

  • COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY INFLUENZA VIRUSES

    The present invention relates to herbal medicine extracts useful in the prevention or treatment of diseases caused by influenza viruses, and to a pharmaceutical composition or health food comprising the extracts. Theherbal medicine extracts of the present invention are derived from natural materials, and are safe for the human body, and can be used in preventing and treating and in relieving symptoms of diseases caused by various types of influenza viruses.

  • COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY INFLUENZA VIRUSES

    The present invention relates to herbal medicine extracts useful in the prevention or treatment of diseases caused by influenza viruses, and to a pharmaceutical composition or health food comprising the extracts. Theherbal medicine extracts of the present invention are derived from natural materials, and are safe for the human body, and can be used in preventing and treating and in relieving symptoms of diseases caused by various types of influenza viruses.

  • TREATMENT AND/OR PREVENTION OF INFLAMMATION AND CUTANEOUS PHOTODAMAGE AND PHOTOPROTECTION OF THE SKIN WITH A WATER-SOLUBLE EXTRACT FROM PLANT OF SOLANUM GENUS

    The present invention relates to a pharmaceutical composition for preventing and treating inflammation and cutaneous photodamage, which contains a water-soluble extract from a plant of Solanum genus. The composition also has a photoprotective effect, and can be used as a cosmetic composition.

  • HUMAN LYSOSOMAL PROTEINS FROM PLANT CELL CULTURE

    A device, system and method for producing glycosylated proteins in plant culture, particularly proteins having a high mannose glycosylation, while targeting such proteins with an ER signal and/or by-passing the Golgi. The invention further relates to vectors and methods for expression and production of enzymatically active high mannose lysosomal enzymes using transgenic plant root, particularly carrot cells. More particularly, the invention relates to host cells, particularly transgenic suspended carrot cells, vectors and methods for high yield expression and production of biologically active high mannose Glucocerebrosidase (GCD). The invention further provides for compositions and methods for the treatment of lysosomal storage diseases

  • Topical Skin Care Formulations Comprising Plant Extracts

    Disclosed is a topical skin composition and corresponding methods for its use that includes a first MMP-1 inhibitor, wherein said first inhibitor is an extract from Burretiodendron hsienmu, a second MMP-1 inhibitor, wherein said second inhibitor is an extract from Bauhinia brachycarpa var. cavaleriei, and a third MMP-1 inhibitor, wherein said third inhibitor is an extract from Tetracentron sinense.

  • TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS

    Disclosed are topical skin compositions and corresponding methods for their use that include plant extracts. One such composition can include a TNF-.alpha. inhibitor, wherein said inhibitor is an aqueous extract from the whole plant of Polygonum multiflorum, an antioxidant and a tyrosinase inhibitor, wherein said antioxidant and tyrosinase inhibitior is an aqueous extract from the whole plant of Lonicera japonica, and a dermatologically acceptable carrier, wherein the composition can include at least 50% by weight of water

  • COMPOSITION COMPRISING PLANT AND/OR FISH OILS AND NON-OXIDIZABLE FATTY ACID ENTITIES

    The present invention concerns a composition prepared from a combination of plant oil and/or fish oil and a compound comprising non. .beta.-oxidizable fatty acid analogues, and the use of said composition for the preparation of a pharmaceutical or nutritional composition for the prevention and/or treatment of insulin resistance, obesity, diabetes, fatty liver, hypercholesterolemia, dyslipidemia, atherosclerosis, coronary heart disease, thrombosis, stenosis, secondary stenosis, myocardial infarction, stroke, elevated blood pressure, endothelial dysfunction, procoagulant state, polycystic ovary syndrome, the metabolic syndrome, cancer, inflammatory disorders and proliferate skin disorders. The present invention also concerns an animal feed prepared from a combination of plant oil and/or fish oil and a compound comprising non .beta.-oxidizable fatty acid analogues, the use of said feed for improving the body composition of an animal, and a product produced from said animal.

  • PLANT EXTRACTS FOR TREATING SKIN DISEASES

    The invention relates to the utilization of an extract or of extracts, of lipophilic extracts as well as hydrophilic extracts from the fruit of the plant Pandanus conoideus for production of topical preparations for the treatment of diseases of skin and of the mucous membrane in the region of the nose, eyes and/or ears, and in particular for treating of dry skin, neurodermatitis, dermatitis, eczemas, psoriasis, metabolic disorders of the skin, acne, damaged skin, symptoms of skin aging and for smoothing the skin, increasing the skin's hydration and for the treatment and prophylaxis of neurodermatitis, dermatitis, eczemas, and psoriasis.

  • COMPOSITIONS AND METHODS OF TREATMENT THAT INCLUDE PLANT EXTRACTS

    The present invention provides for a pharmaceutical composition that provides for the symptomatic relief to an animal (e.g., mammal, such as a human) afflicted with inflammation. The pharmaceutical composition includes a pharmaceutically acceptable carrier and at least two of: (a) sunflower extract, (b) rhubarb root extract, (c) milk thistle extract, (d) dandelion extract, (e) feverfew extract, and (f) ginger extract. The present invention also provides for a method for providing symptomatic relief to a human afflicted with inflammation. The method includes administering to a patient in need of such symptomatic relief an effective amount of the pharmaceutical composition described herein, for a period of time sufficient to provide symptomatic relief to the human.

  • PLANT REGULATORY ELEMENTS AND USES THEREOF

    The present invention provides novel DNA molecules and constructs, including their nucleotide sequences, useful for modulating gene expression in plants and plant cells. The invention also provides transgenic plants, plant cells, plant parts, seeds, and commodity products comprising the DNA molecules operably linked to heterologous transcribable polynucleotides, along with methods of their use.

  • CYCLOTIDE GENES IN THE FABACEAE PLANT FAMILY

    The present invention relates to cyclotides and cyclotide-encoding genes from the Fabaceae plant family, and to the expression of cyclotides in Fabaceae. The present invention further relates to isolated nucleic acids configured to express cyclotides comprising heterologous peptide grafts in plants of the Fabaceae family.

  • VIRUS LIKE PARTICLES COMPRISING TARGET PROTEINS FUSED TO PLANT VIRAL COAT PROTEINS

    Virus like particles comprising a fusion protein and substantially free of nucleic acid, wherein the fusion protein comprises a plant viral coat protein and a target protein, are provided. Immunogenic compositions comprising the virus like particles can be administered to subjects to induce protective immune responses in the subjects. Methods of producing the virus like particles are also provided.

  • METHOD FOR MODULATING PLANT GROWTH, NUCLEIC ACID MOLECULES AND POLYPEPTIDES ENCODED THEREOF USEFUL AS MODULATING AGENT

    The invention provides isolated nucleic acids molecules, designated CCP nucleic acid molecules, which encode novel cell cycle associated polypeptides. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CCP nucleic acid molecules, host cells into which the expression vectors have been introduced, and transgenic plants in which a CCP gene has been introduced or disrupted. The invention still further provides isolated CCP proteins, fusion proteins, antigenic peptides and anti-CCP antibodies. Agricultural, diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.

  • NUCLEOTIDE SEQUENCES AND CORRESPONDING POLYPEPTIDES CONFERRING MODULATED PLANT CHARACTERISTICS

    The present invention relates to isolated nucleic acid molecules and their corresponding encoded polypeptides. The present invention further relates to the uses of these nucleic acid molecules and polypeptides. For example, the nucleic acid molecules and polypeptides could be used in making enzymes or used to make plants, plant cells, plant materials or seeds of a plant having such modulated growth or phenotype characteristics that are altered with respect to wild type plants grown under similar conditions.

  • PHARMACEUTICAL COMPOSITIONS COMPRISING PLANT-BASED POLYSACCHARIDES AND USES THEREOF

    A composition for providing relief to a discomfort of an eye comprises a pharmaceutically acceptable carrier and a polysaccharide extracted from a plant source. In certain embodiments, such a polysaccharide can be extracted from mushrooms, such as from the Tremella fuciformis species. The composition is administered to an affected eye to provide such relief or discomfort.

  • PLANT REGULATORY ELEMENTS AND USES THEREOF

    The invention provides DNA molecules and constructs, and their nucleotide sequences, useful for modulating gene expression in plants, and for specifying intracellular or extracellular localization of a gene product of interest. Transgenic plants, plant cells, plant parts, and seeds, comprising the DNA molecules operably linked to heterologous transcribable polynucleotides are also provided.

  • Process for Manufacturing Soluble and Functional Plant Proteins, Products Obtained and Uses

    The invention relates to a process for manufacturing soluble and functional plant proteins, characterized in that it comprises at least one functionalizing step that consists of a treatment of 0.01 s to 1 s constituted of a step of heating plant proteins at a temperature of 100.degree. C. to 160.degree. C. and a step of cooling the heated plant proteins. The invention also relates to a process for converting non-functional plant proteins to functional proteins. Another subject of the invention is a plant protein, characterized in that it has a solubility in water of greater than 50% (with the exception of a potato protein for which the solubility in water is 25%), an emulsifying capacity between 700,000 mPas and 1,200,000 mPas for a sample directly placed at 4.degree. C. for 24 h (with the exception of a potato protein for which the emulsifying capacity for a sample directly placed at 4.degree. C. for 24 h is between 400,000 mPas and 600,000 mPas) and between 500,000 mPas and 1,100,000 mPas for a sample treated at 75.degree. C. then placed at 4.degree. C. for 24 h and an emulsifying capacity between 70% and 95%. A further subject of the invention is the use of said plant protein in the manufacture of food.

  • NATURAL PLANT PRODUCTS FOR CONTROL OF CANCER METASTASIS

    The invention provides compositions comprising soluble extracts or isolated polypeptides from the edible roots of the plant Colocasia, such as Colocasia esculenta, commonly known as Taro, and from Xanthosoma, such as Xanthosoma sagittifolium, commonly known as Malanga Blanca or Yautia. The compositions exhibit inhibitory effects on metastasis of cancer cells in particular breast and prostate cancer cells and have therapeutic pharmacological activity, Pharmaceutical compositions for the treatment of cancer by inhibiting metastasis which comprises an effective amount of the described extract or isolated polypeptide thereof and optionally a pharmaceutical acceptable carrier are described.

  • PLANT EXTRACT FROM LOW-THC CANNABIS FOR THE TREATMENT OF DISEASE

    The present invention relates to a plant extract from a low-tetrahydrocannabinol (THC) variety of Cannabis sativa subsp. sativa for the treatment of disease. The invention further relates to the production of the extract and pharmaceutical compositions comprising said extract and the uses thereof.

  • PLANT DISEASE CONTROLLING COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE

    The present invention provides a composition having an excellent controlling activity on plant disease. The composition comprising the compound represented by the formula (1) and one or more azole fungicidal compound selected from the group (A) shows an excellent controlling activity on a plant disease. group (A): a group consisting of triadimenol, bitertanol, oxpoconazole fumarate, tebuconazole, cyazofamid, pefurazoate, triflumizole, hymexazol, and etridiazole ##STR00001##

  • PLANT DISEASE CONTROLLING COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE

    The present invention provides a composition having an excellent controlling activity on plant disease. The composition comprising the compound represented by the formula (1) and one or more azole fungicidal compound selected from the group (A) shows an excellent controlling activity on a plant disease. group (A): a group consisting of triadimenol, bitertanol, oxpoconazole fumarate, tebuconazole, cyazofamid, pefurazoate, triflumizole, hymexazol, and etridiazole ##STR00001##

  • ADMINISTRATION OF PLANT EXPRESSED ORAL TOLERANCE AGENTS

    Protein replacement therapy for patients with hemophilia or other inherited protein deficiencies is often complicated by pathogenic antibody responses, including antibodies that neutralize the therapeutic protein or that predispose to potentially life-threatening anaphylactic reactions by formation of IgE. Using murine hemophilia B as a model, we have developed a prophylactic protocol against such responses that is non-invasive and does not include immune suppression or genetic manipulation of the patient's cells. Oral delivery of coagulation factor IX (F. IX) expressed in chloroplasts, bioencapsulated in plant cells, effectively blocked formation of inhibitory antibodies in protein replacement therapy. Inhibitor titers were mostly undetectable and up to 100-fold lower in treated mice when compared to controls. Moreover, this treatment eliminated fatal anaphylactic reactions that occurred after 4 to 6 exposures to intravenous F. IX protein. While only 20-25% of control animals survived after 6-8 F. IX doses, 90-95% of tolerized mice survived 12 injections without signs of allergy or anaphylaxis. This high-responder strain of hemophilia B mice represents the first hemophilic animal model to study anaphylactic reactions. The plant material was effective over a range of oral antigen doses (equivalent to 5-80 .mu.g recombinant F.IX/kg), and controlled inhibitor formation and anaphylaxis long-term, up to 7 months. Oral antigen administration caused a deviant immune response that suppressed formation of IgE and inhibitory antibodies. This cost-effective and efficient approach to oral delivery of protein antigens to the gut should be applicable to several genetic diseases that are prone to pathogenic antibody responses during treatment.

  • STOMATA-INCREASING AGENT, POLYPEPTIDE, METHOD FOR INCREASING NUMBER AND/OR DENSITY OF STOMATA IN PLANT, AND METHOD FOR INCREASING YIELD OF PLANT

    A stomata-increasing agent containing a compound capable of increasing the number and/or density of stomata in a plant, a polypeptide containing the amino acid sequence shown in SEQ ID NO: 6 or a variant thereof, a method for increasing the number and/or density of stomata in a plant and a method for increasing the yield of a plant are provided.

  • STOMATA-INCREASING AGENT, POLYPEPTIDE, METHOD FOR INCREASING NUMBER AND/OR DENSITY OF STOMATA IN PLANT, AND METHOD FOR INCREASING YIELD OF PLANT

    A stomata-increasing agent containing a compound capable of increasing the number and/or density of stomata in a plant, a polypeptide containing the amino acid sequence shown in SEQ ID NO: 6 or a variant thereof, a method for increasing the number and/or density of stomata in a plant and a method for increasing the yield of a plant are provided.

  • Use of Plant Lectins to Target Leukocytes

    The present invention provides compositions and methods for targeting an antigen to leukocytes, delivering an antigen to leukocytes, increasing antigen uptake by leukocytes, and/or enhancing an immune response. In some embodiments, compositions and methods of the present invention comprise a conjugate comprising an antigen and a plant lectin or a mimetic thereof.

  • Use of Plant Lectins to Target Leukocytes

    The present invention provides compositions and methods for targeting an antigen to leukocytes, delivering an antigen to leukocytes, increasing antigen uptake by leukocytes, and/or enhancing an immune response. In some embodiments, compositions and methods of the present invention comprise a conjugate comprising an antigen and a plant lectin or a mimetic thereof.

  • CAROTENOID EXTRACTION FROM PLANT MATERIAL

    A method of extracting carotenoids from plant material generally includes acquiring plant material including carotenoids, treating the carotenoids with a first enzyme to create a first enzyme treated mixture, wherein the first enzyme includes cellulase, and separating the first enzyme extracted carotenoids from the first enzyme treated mixture. Natural carotenoid concentrate obtained from plant material are also provided.

  • HIGH-PURITY STEVIOL GLYCOSIDES

    Methods of preparing highly purified steviol glycosides, particularly Rebaudioside D, are described. The methods include purification from the extraction stage of the Stevia rebaudiana Bertoni plant, purification of steviol glycoside mixtures, Rebaudioside D and Rebaudioside A from a commercial Stevia extract, and purification of Rebaudioside D from remaining solutions obtained after isolation and purification of Rebaudioside A and a high purity mixture of steviol glycosides. The methods are useful for producing high purity Rebaudioside D, Rebaudioside A, and steviol glycoside mixtures. The high purity steviol glycosides are useful as non-caloric sweeteners in edible and chewable compositions such as any beverages, confectioneries, bakery products, cookies, and chewing gums.

  • POLAR ORGANIC EXTRACT OF EURYCOMA LONGIFOLIA

    The present invention provides a composition including a polar organic extract of Eurycoma longifolia and a fraction derived from the polar organic extract, said composition comprising of quassinoids, coumarins, their glycosides, analogues and derivatives, which exhibits bioactivity of increasing spermatozoa production and spermatozoa quality in terms of morphology and motility, as well as increasing testosterone synthesis and release from cells of males. The extraction method of E. longifolia plant to produce the polar organic extract, and the subsequent purification to produce the fraction of polar organic extract containing the quassinoids, coumarins, their glycosides, analogues and derivatives, and uses for manufacturing a preparation for infertility treatment are also provided. The fraction of polar organic extract containing the quassinoids, coumarins, their glycosides, analogues and derivatives is formulated for medical applications via several routes of administration.

  • Tangential Flow Particle Separator and Method Therefor

    A particle separating apparatus for fluids containing particulate material, treatment system for treating effluent from a processing plant, and a method of separating particles from fluid. A treatment vessel has an inlet for injecting fluid containing particulate material, and a plurality of outlets for separately discharging separated supernatant on the one hand, and separated particles on the other hand, from the fluid. An outer annular treatment region receives fluid injected tangentially into said treatment vessel from the inlet and directs the fluid into a transverse, laminar flow within the vessel about a central axis. An inner particle separating region communicates with the outer treatment region but is separated therefrom by a baffle to permit ingress of the injected fluid gradually from the transverse flow in a radially converging manner that maintains the laminar flow for fluid. The fluid eventually reposes centrally of the treatment vessel for optimum residency in the inner particle separating region. The baffle mitigates the effects of the angular fluid motion in the outer annular treatment region on fluid within the inner separating region. A lower particle collection region communicates with both the lower portion of the outer treatment region and said inner particle separating region for receiving separated particles from the fluid having a higher specific gravity. An upper supernatant separating region communicates with the top of the inner particle separating region for egressing supernatant from the fluid for extraction. The baffle has a recess opening from the depending thereof behind the inlet and spanning a sector of approximately 90.degree..

  • METHOD FOR PREPARING EXTRACT CONTAINING OMEGA FATTY ACIDS FROM PLANT BY USING SUPERCRITICAL CARBON DIOXIDE EXTRACTION

    The present invention relates to a method for preparing an extract containing omega fatty acids from a plant containing omega fatty acids, including the following steps: drying the plant containing omega fatty acids to prepare a powder; and extracting omega fatty acids from the prepared plant powder by using supercritical carbon dioxide as a solvent at an optimum temperature and pressure, a dietary supplement and a cholesterol-lowering pharmaceutical composition containing plant-derived omega fatty acids extracted by the method, and omega fatty acids-containing plant extract containing a predetermined or greater amount of omega-3 fatty acids.

  • PROCESSING OF SUNFLOWER EXTRACTION MEAL

    With a method as well as a system for processing of sunflower extraction grist, particularly for obtaining proteins, wherein the particles from shell kernel parts and adhering proteins of the extraction grist are separated from one another by means of screening, a solution is to be created for processing the extraction grist of sunflowers, which occurs in the production of sunflower oil, in such a manner that it can be utilized in many different ways and, in particular, in practical manner. This is achieved, in terms of method, by means of the following steps: comminuting the grist by means of breaking it in beater impact mills (3) and/or corrugated rollers (16), screening the mixture of coarse and fine particles produced, separating the plant shells (fibers) and proteins by using water (5, 18), drying (6) the components, and pressing (8) the woody components into pellets as fuel for energy production.

  • Herbal Supplement Prepared From Pelargonium Citronellum

    An extraction method for extracts of Pelargonium citronellum with improved methylhexaneamine content is provided. The method involves separating the oil phase from the aqueous phase; concentrating the aqueous phase; purifying the oil phase; and recombining the resulting material. Additionally, extracts of Pelargonium citronellum prepared by the extraction method are provided. The extracts are useful in compositions, for example as dietary supplements, and for appetite suppression.

  • NOVEL HERBAL OIL FOR CONTROLLING BLOOD SUGAR WITHOUT RISK OF HYPOGLYCEMEA

    The invention relates to a herbal oil, for controlling blood sugar without risk of hypoglycemia, comprising of the step of (i) fractional distillation of essential oils comprising of turpentine oil, jasmine oil, rose oil, eucalyptus oil, sandal wood oil and water green oil to obtain hydroxyl compounds #-terpinol, linalool, Gereneol, Citroneoll, #-Santalol, Methyl salicylate and other alcoholic terpenoils and (ii) dilution with fat oil so as to have approximate weight percentage of #-terpinol 50%, linalool 6%, Gereneol 4%, Citroneoll 3.5%, #-Santalol 2.7%, Methyl salicylate 2%, other alcoholic terpenoils and fat oil 31.8%.

  • METHOD OF PRODUCING A CHINESE HERBAL COMPOSITION FOR TREATING TERMINAL CANCER PATIENTS WITH CONSTIPATION

    Constipation is a common and serious problem for terminal cancer patients, often resulting in deterioration of the overall condition of the patients and causing great anxiety in their family members. Terminal cancer patients, according to the principle of palliative care and the symptoms of pain, are usually given morphine-like analgesics orally or by injection to ease the pain, and are therefore very likely to suffer from constipation, poor appetite, bloating and other relevant symptoms. The Chinese herbal composition of rhubarb and licorice extracts presented in this study can notably improve the symptoms of constipation, poor appetite, and bloating, and these results are statistically significant.

  • NATURAL SOAP USING HERBAL MEDICINE MATURE DECOCTION, AND METHOD OF PREPARING THE SAME

    A natural soap is provided. The natural soap is made using a herbal medicine mature decoction which is obtained by putting herbs including lotus roots, lotus leaves, red ginseng, Hippophae rhamnoides leaves and trunk, persimmon leaves, thuja orientalis, ginger, rosemary, black beans, black sesame, aloe, mulberry leaves, Orostachys japonicus, Angelica gigas, green tea, pine needles, mint, pleuropterus multflorus, blueberry, and Acorus gramineus in a maturing device, maturing the herbs in temperatures of 65 to 95.degree. C. depending on the herb for 3 to 15 days, then pouring distilled water or soft water, and decocting the matured herbs mixed with the water.

  • HERBAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF URINARY INCONTINENCE AND OVERACTIVE BLADDER

    Provided in one embodiment is an herbal compositions for the prevention or treatment of urogenital system disorders including urinary incontinence, overactive bladder, enuresis, benign prostatic hyperplasia, nocturia, cystitis, urinary calculi, or a urinary tract infection. Specifically one embodiment provides compositions that contain Crateva nurvala, Equisetum arvense, and Lindera aggregata and methods of use thereof.

  • COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF

    Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.

  • HERBAL COMPOSITION FOR PREVENTING AND/OR TREATING ANXIETY RELATED CONDITIONS

    The present invention relates to herbal compositions for the treatment and/or prevention of anxiety disorders or stress. These compositions comprise hawthorn fruit (Shan Zha), light wheat grain (Fu xiao mai) and Lilly Bulb (bai hi) in amounts which are effective to treat anxiety conditions. The compositions may further comprise Chinese date (Da zao).

  • HERBAL EXTRACT COMPOSITION

    The present invention relates to the field of herbal compositions. In particular, the present invention is directed to an Improved Herbal Extract Composition comprising a Melissa species extract, an Avena species extract, a Tilia species extract and a unique blend of citrus components. The composition can further comprise at least one additional extract of a plant such as Citrus species, Crataegus species, Panax species, and Lavendula species. The herbal extract composition is useful in numerous ingestible forms including an extract concentrate for food and beverage preparation, additive or enhancer for existing foods and beverages and particularly in the form of a pleasant tasting and soothing beverage.